Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 2/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.40 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.40 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.40 |
| ▸ | ARG1 | P05089 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29136392 | 0.84 | CYP1A2 (0.39) | CYP2D6ALOX15CYP1A2CYP2C19SLC1A3 | |
| SCHEMBL19143766 | 0.78 | CYP2D6 (0.42) | CYP2D6ALOX15CYP1A2CYP2C19SLC1A3 | |
| SCHEMBL17422956 | 0.78 | CYP2D6 (0.44) | CYP2D6ALOX15CYP1A2CYP2C19SLC1A3 | |
| SCHEMBL5068419 | 0.78 | CYP2D6 (0.44) | CYP2D6ALOX15CYP1A2CYP2C19SLC1A3 | |
| SCHEMBL3450044 | 0.75 | CYP2D6 (0.48) | CYP2D6ALOX15CYP1A2CYP2C19SLC1A3 | |
| SCHEMBL683739 | 0.75 | CYP2D6 (0.48) | CYP2D6ALOX15CYP1A2CYP2C19SLC1A3 | |
| SCHEMBL5861606 | 0.75 | CYP2D6 (0.48) | CYP2D6ALOX15CYP1A2CYP2C19SLC1A3 | |
| SCHEMBL3450045 | 0.75 | CYP2D6 (0.48) | CYP2D6ALOX15CYP1A2CYP2C19SLC1A3 | |
| SCHEMBL23610412 | 0.74 | CYP2D6 (0.47) | CYP2D6ALOX15CYP1A2CYP2C19SLC1A3 | |
| SCHEMBL3824571 | 0.74 | CYP2D6 (0.47) | CYP2D6ALOX15CYP1A2CYP2C19SLC1A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110034654-A1 | POLYMER ORGANOCATALYST AND PREPARATION PROCESS | UNIVERSITETET I OSLO (NO) | 2011-02-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110034654-A1 | POLYMER ORGANOCATALYST AND PREPARATION PROCESS | HRH3, HRH4, H1-3 | CYP2D6 1481/4885ALOX15 3446/4885CYP1A2 1318/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.